Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

p53 expression in fallopian tube carcinomas.

A C Rosen1, C Ausch, M Klein

  • 1Department of Obstetrics and Gynaecology, Danube Hospital, SMZ-Ost, Langobardenstrasse 122, A-1220, Vienna, Austria. alexander.rosen@smz.magwien.gv.at

Cancer Letters
|June 7, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anatomical and fMRI-network comparison of multiple DLPFC targeting strategies for repetitive transcranial magnetic stimulation treatment of depression.

Brain stimulation·2021
Same author

Rescue of BDNF expression by the thalamic parafascicular nucleus with chronic treatment with the mGluR2/3 agonist LY379268 may contribute to the LY379268 rescue of enkephalinergic striatal projection neurons in R6/2 Huntington's disease mice.

Neuroscience letters·2021
Same author

Targeting location relates to treatment response in active but not sham rTMS stimulation.

Brain stimulation·2021
Same author

Embryoscopy and karyotype findings of repeated miscarriages in recurrent pregnancy loss and spontaneous pregnancy loss.

Journal of assisted reproduction and genetics·2018
Same author

Prospective associations of C-reactive protein (CRP) levels and CRP genetic risk scores with risk of total knee and hip replacement for osteoarthritis in a diverse cohort.

Osteoarthritis and cartilage·2018
Same author

Effect of early embryonic deletion of huntingtin from pyramidal neurons on the development and long-term survival of neurons in cerebral cortex and striatum.

Neurobiology of disease·2017
Same journal

RETRACTED: Novel target genes responsive to the anti-growth activity of triptolide in endometrial and ovarian cancer cells.

Cancer letters·2026
Same journal

FGFR2 Fusion-Driven CXCL3 Downregulation Attenuates Neutrophil Recruitment in Intrahepatic Cholangiocarcinoma.

Cancer letters·2026
Same journal

Dissection of spatial hypoxic and inflammatory ecosystem in glioblastoma.

Cancer letters·2026
Same journal

An IL-15 fusion with albumin-binding domain boosts Immunotherapy therapy in glioblastoma via FGF-2 competition regulating FGFR1/2.

Cancer letters·2026
Same journal

Stress-adapted cancer-associated fibroblasts as mediators of immunosuppression and therapy resistance.

Cancer letters·2026
Same journal

Aldo-keto Reductase Family 1 Member C3 Suppresses Glioma Progression via Inhibiting Prostaglandin D2-Dependent RhoA/ROCK Signaling.

Cancer letters·2026
See all related articles

This study analyzed p53 expression in primary fallopian tube cancer (PFTC) patients. P53-negative tumors showed a trend towards better survival, suggesting p53

Area of Science:

  • Gynecologic Oncology
  • Molecular Pathology
  • Cancer Research

Background:

  • Primary fallopian tube carcinoma (PFTC) is a rare gynecologic malignancy.
  • Understanding prognostic factors is crucial for improving patient outcomes.
  • The role of p53 tumor suppressor gene expression in PFTC survival is not well-established.

Purpose of the Study:

  • To investigate the impact of p53 expression on survival in patients with primary fallopian tube carcinoma.
  • To correlate p53 expression with clinicopathological features and FIGO staging.

Main Methods:

  • Retrospective analysis of 63 women diagnosed with PFTC between 1980 and 1995.
  • Assessment of p53 expression via immunohistochemistry (nuclear staining).
  • Correlation of p53 status with FIGO stage, treatment modalities, and survival data.

Related Experiment Videos

Main Results:

  • The overall 5-year survival rate was 43%, with significant differences based on FIGO stage (59% for stages I+II vs. 19% for stages III+IV).
  • p53 expression was observed in 81% of tumors; 19% were p53-negative.
  • Median survival was 40 months for p53-negative and 21 months for p53-positive groups, indicating a trend for better survival in p53-negative cases.

Conclusions:

  • p53 expression may serve as a potential prognostic marker in primary fallopian tube carcinoma.
  • While not statistically significant in this cohort, p53-negative tumors showed a trend towards improved survival.
  • Further research is warranted to elucidate the precise role of p53 in PFTC pathogenesis and prognosis.